S. 164 · 117th Congress · 2021–2022
Advancing Education on Biosimilars Act of 2021
S. 164 in the 117th Congress (2021–2022) became law — introduced on Feb 2, 2021, sponsored by Margaret Wood Hassan with 1 co-sponsors. Congress held 1 roll call vote on it.
During the 117th Congress (2021–2022), Joe Biden was president, and Democrats held the House majority and Republicans the Senate majority.
- Status
- Became law
- Introduced
- Feb 2, 2021
- Co-sponsors
- 1
- Policy area
- Health
- Public law
- Public Law 117-8
What it does
Advancing Education on Biosimilars Act of 2021 This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars.
Summary by the nonpartisan Congressional Research Service.
Sponsor
Margaret Wood Hassan (D-NH). Co-sponsors: 1 Republican.
Where it stands
- IntroducedFeb 2, 2021
- Passed the SenateMar 3, 2021
- Passed the HouseApr 14, 2021
- Sent to the PresidentApr 20, 2021
- Became lawApr 23, 2021
Latest action: Became Public Law No: 117-8. (Apr 23, 2021)
How Congress voted
- On Motion to Suspend the Rules and Pass
House · Apr 14, 2021 · Passed412–8
Every roll call vote on this bill
- Advancing Education on Biosimilars ActHouse · Apr 14, 2021
More bills from Margaret Wood Hassan in the 117th Congress
Other Health bills in the 117th Congress
- H.R. 1868: To prevent across-the-board direct spending cuts, and for other purposes.
- S. 415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical…
- S. 578: Food Allergy Safety, Treatment, Education, and Research Act of 2021
- H.R. 941: TRANSPLANT Act of 2021
- S. 610: Protecting Medicare and American Farmers from Sequester Cuts Act
- H.R. 3537: Accelerating Access to Critical Therapies for ALS Act
- S. 1543: STANDUP Act of 2021
- S. 1662: Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation…
- H.R. 189: John Lewis NIMHD Research Endowment Revitalization Act of 2021
- H.R. 1667: Dr. Lorna Breen Health Care Provider Protection Act
Committees
More
From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.
Cite or embed this page
Capitol Receipts, “S. 164 (117th Congress): Advancing Education on Biosimilars Act of…,” https://www.capitolreceipts.com/bill/117-s-164/advancing-education-on-biosimilars-act-of-2021 (accessed 2026-10-17).